Join Date
August 2024
Country
Gender
Not Specified
Age
Not Specified
About Celestin de
Co-founder of Signatur Biosciences
Companies & Work
Signatur Biosciences
We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.
